- Home
- CVAC vs CRAI Comparison
CVAC vs CRAI Comparison
Compare CVAC & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- CRAI
- Stock Information
- Founded
- CVAC 2000
- CRAI 1965
- Country
- CVAC Germany
- CRAI United States
- Employees
- CVAC N/A
- CRAI N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- CRAI Other Consumer Services
- Sector
- CVAC Health Care
- CRAI Consumer Discretionary
- Exchange
- CVAC Nasdaq
- CRAI Nasdaq
- Market Cap
- CVAC 1.2B
- CRAI 1.3B
- IPO Year
- CVAC 2020
- CRAI 1998
- Fundamental
- Price
- CVAC $5.35
- CRAI $204.93
- Analyst Decision
- CVAC Hold
- CRAI Buy
- Analyst Count
- CVAC 3
- CRAI 1
- Target Price
- CVAC $6.83
- CRAI $228.00
- AVG Volume (30 Days)
- CVAC 471.1K
- CRAI 79.6K
- Earning Date
- CVAC 11-11-2025
- CRAI 10-30-2025
- Dividend Yield
- CVAC N/A
- CRAI 0.96%
- EPS Growth
- CVAC N/A
- CRAI 44.21
- EPS
- CVAC 1.01
- CRAI 8.27
- Revenue
- CVAC $599,540,810.00
- CRAI $712,913,000.00
- Revenue This Year
- CVAC N/A
- CRAI $9.01
- Revenue Next Year
- CVAC $23.95
- CRAI $4.26
- P/E Ratio
- CVAC $5.32
- CRAI $24.60
- Revenue Growth
- CVAC 675.15
- CRAI 9.28
- 52 Week Low
- CVAC $2.37
- CRAI $152.57
- 52 Week High
- CVAC $5.72
- CRAI $214.01
- Technical
- Relative Strength Index (RSI)
- CVAC 44.43
- CRAI 65.06
- Support Level
- CVAC $5.32
- CRAI $196.07
- Resistance Level
- CVAC $5.41
- CRAI $198.89
- Average True Range (ATR)
- CVAC 0.04
- CRAI 4.93
- MACD
- CVAC -0.01
- CRAI 0.63
- Stochastic Oscillator
- CVAC 33.33
- CRAI 93.37
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About CRAI CRA International Inc.
CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.